BioCentury
ARTICLE | Clinical News

Dendritic cell therapy: Phase I and II Update

May 27, 1997 7:00 AM UTC

Activated Cell Therapy Inc., Mountain View, Calif. Product: Dendritic cell therapy Indication: Advanced prostate cancer Status: The company began Phase I/II trials in which cells are taken from patien...